360 related articles for article (PubMed ID: 19746834)
1. Pharmaceutical product development technologies based on the biopharmaceutical classification system.
Jain D; Pathak D; Pathak K
Pharmazie; 2009 Aug; 64(8):483-90. PubMed ID: 19746834
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical profiling (solubility, permeability and charge state).
Avdeef A
Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
[TBL] [Abstract][Full Text] [Related]
3. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.
Lennernäs H; Abrahamsson B
J Pharm Pharmacol; 2005 Mar; 57(3):273-85. PubMed ID: 15807982
[TBL] [Abstract][Full Text] [Related]
4. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Mar; 65(3):155-61. PubMed ID: 20383933
[TBL] [Abstract][Full Text] [Related]
5. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
6. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
[TBL] [Abstract][Full Text] [Related]
7. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
8. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
Golovenko NIa; Borisiuk IIu
Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
[TBL] [Abstract][Full Text] [Related]
9. The use of drug metabolism for prediction of intestinal permeability (dagger).
Chen ML; Yu L
Mol Pharm; 2009; 6(1):74-81. PubMed ID: 19132929
[TBL] [Abstract][Full Text] [Related]
10. When poor solubility becomes an issue: from early stage to proof of concept.
Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
[TBL] [Abstract][Full Text] [Related]
11. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
Dokoumetzidis A; Macheras P
Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research.
Varma MV; Khandavilli S; Ashokraj Y; Jain A; Dhanikula A; Sood A; Thomas NS; Pillai O; Sharma P; Gandhi R; Agrawal S; Nair V; Panchagnula R
Curr Drug Metab; 2004 Oct; 5(5):375-88. PubMed ID: 15544432
[TBL] [Abstract][Full Text] [Related]
13. Very rapid dissolution is not needed to guarantee bioequivalence for biopharmaceutics classification system (BCS) I drugs.
Kortejärvi H; Shawahna R; Koski A; Malkki J; Ojala K; Yliperttula M
J Pharm Sci; 2010 Feb; 99(2):621-5. PubMed ID: 19844950
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H
Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726
[TBL] [Abstract][Full Text] [Related]
15. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
Lindenberg M; Kopp S; Dressman JB
Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
[TBL] [Abstract][Full Text] [Related]
16. Paediatric biopharmaceutics classification system: current status and future decisions.
Batchelor H;
Int J Pharm; 2014 Aug; 469(2):251-3. PubMed ID: 24602991
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the feasibility of oral controlled release in an exploratory development setting.
Thombre AG
Drug Discov Today; 2005 Sep; 10(17):1159-66. PubMed ID: 16182208
[TBL] [Abstract][Full Text] [Related]
18. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
Zaki NM; Artursson P; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
Alavijeh MS; Palmer AM
IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
